The psychological burden of cystic fibrosis

Current Opinion in Pulmonary Medicine
Alexandra L QuittnerJohn D Barton

Abstract

Cystic fibrosis (CF) is the most common genetic, life-shortening illness among white populations. Management of the disease requires a complex, time-consuming treatment regimen. The purpose of this review is to highlight current research examining the psychological burden of CF, including psychological distress, social challenges, treatment burden, and adherence to daily treatments. Individuals with CF and their parent caregivers report elevated symptoms of depression and anxiety. Recent international guidelines (Cystic Fibrosis Foundation and European Cystic Fibrosis Society) recommend annual screening of these symptoms using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales. Symptoms of depression have been associated with decreased adherence, lower quality of life, and higher healthcare costs. Adherence to pulmonary medications has been found to be 50% or less and decreases with age. Poor adherence has been associated with higher healthcare costs, more frequent hospitalizations, and worse quality of life. Individuals with CF face unique challenges that can lead to psychological burden. Screening for these symptoms and developing effective interventions to improve adherence are the k...Continue Reading

References

May 3, 2006·Health & Social Care in the Community·Kathryn Badlan
May 1, 2007·Clinics in Chest Medicine·Steven D Strausbaugh, Pamela B Davis
Aug 12, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Trudy HavermansLieven J Dupont
Mar 23, 2010·Journal of Pediatric Psychology·Avani C ModiRichard F Ittenbach
Nov 23, 2010·Journal of Pediatric Psychology·Martin Pinquart, Yuhui Shen
Mar 9, 2011·Pediatric Pulmonology·Tanja BesierUNKNOWN TIDES Study Group
Apr 2, 2011·The American Journal of Hospice & Palliative Care·Karen R FaumanAnn Marie LeVine
Apr 5, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Michelle N EakinKristin A Riekert
Nov 4, 2011·The New England Journal of Medicine·Bonnie W RamseyUNKNOWN VX08-770-102 Study Group
Jan 29, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Gregory S SawickiUNKNOWN Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis
Mar 12, 2013·Psychosomatics·Beth A SmithGeorgina Garcia
May 1, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Gary Latchford, Alistair J A Duff
Feb 1, 2014·Chest·Alexandra L QuittnerKristin A Riekert
Mar 13, 2014·Pediatric Pulmonology·Gregory S SawickiWalter M Robinson
Mar 13, 2014·Pediatric Pulmonology·Carolyn SnellGeorgina Garcia
May 6, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Kendea N OliverCharles F Emery
Jun 3, 2014·BMC Pulmonary Medicine·Smita PakhaleLouise Balfour
Jul 12, 2014·Journal of Affective Disorders·Mingdi JiangXu Yang
Jul 16, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lisa SaimanDavid J Weber
Aug 7, 2014·Journal of Pediatric Psychology·Sarah W HelmsMitchell J Prinstein
Aug 12, 2014·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Marisa E HilliardKristin A Riekert
May 20, 2015·The New England Journal of Medicine·Claire E WainwrightUNKNOWN TRANSPORT Study Group

❮ Previous
Next ❯

Citations

Apr 14, 2016·Pediatric Pulmonology·Edith T ZemanickCharles R Esther
Oct 16, 2016·Canadian Journal of Diabetes·Valérie BoudreauRémi Rabasa-Lhoret
Jan 22, 2017·Expert Review of Respiratory Medicine·Siva NarayananDaniel Grossoehme
Feb 20, 2018·Pediatric Pulmonology·Aarti ShakkottaiSamya Z Nasr
Nov 16, 2017·American Journal of Medical Genetics. Part a·Marcia Van RiperKathleen A Knafl
Oct 19, 2017·Palliative & Supportive Care·Ann WojtaszczykLara Dhingra
Jan 19, 2019·The European Respiratory Journal·Francesco BlasiPaolo Palange
Apr 17, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Olufunmilola Abraham, Ashley Morris
Oct 29, 2018·Journal of Clinical Psychology in Medical Settings·Robin S EverhartMichael S Schechter
Jul 4, 2019·Western Journal of Nursing Research·Elizabeth T TrandelDio Kavalieratos
Apr 16, 2020·Family Process·Shirli WernerShifra Kurtz
May 7, 2020·JMIR Research Protocols·Irushi RatnayakeRasa Ruseckaite
May 10, 2020·Pediatric Pulmonology·Elizabeth T TrandelElisabeth P Dellon
Aug 4, 2020·Expert Opinion on Investigational Drugs·Ranjani SomayajiScott C Bell
Mar 11, 2020·Frontiers in Pharmacology·Miquéias Lopes-Pacheco
Jun 11, 2020·Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo·Bianca Sampaio BonfimEdna Lúcia Souza
Jan 13, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Christopher McNamaraJohn McNamara
Apr 10, 2018·Work : a Journal of Prevention, Assessment, and Rehabilitation·Pablo S SaldanaMary Ellen Young
Jun 13, 2020·Pediatric Pulmonology·Burcu Pınar SenkalfaMustafa N İlhan
Dec 10, 2020·Pediatric Pulmonology·Michelle L GillespieKatelyn Krivchenia
Dec 22, 2019·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Elizabeth T TrandelDio Kavalieratos
Mar 7, 2021·Pediatric Pulmonology·Elizabeth HenteChristopher Siracusa
Apr 18, 2021·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·V Vion GenoveseC Llerena
Jun 19, 2019·Revue des maladies respiratoires·V Vion GenoveseC Llerena

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.